The U.S. Army has cleared the M111 offensive hand grenade for procurement, the first new lethal hand grenade model to enter the service’s inventory since the M67 fragmentation grenade arrived in 1968. Federal procurement records confirm the Army is actively seeking manufacturers for the M111 alongside continued production of the M67, a development that signals a significant shift in how infantry units will equip for close-quarters combat over the coming years.
For more than five decades, American soldiers have relied on a single lethal hand grenade design. The M111’s emergence breaks that long streak and raises practical questions about production timelines, tactical applications, and whether the defense industrial base can deliver at scale. The available evidence, drawn from official government solicitations, provides a clear but incomplete picture of where this program stands.
What is verified so far
The strongest evidence comes directly from the federal government’s contract portal. A solicitation posted on the sam.gov database under reference number W519TC25R0038 groups three munitions together: the M67 Hand Fragmentation grenade, the M111 Hand Offensive grenade, and the M112 Practice Body. The listing is categorized as a “Solicitation / Sources Sought,” meaning the Army is formally identifying companies capable of producing these items. That classification tells us the service has moved past internal development and is preparing for industrial-scale manufacturing.
Two additional solicitations reinforce the procurement push. A related notice carries the same reference number and covers the identical trio of grenade types, indicating the Army issued multiple rounds of market research or expanded its search for qualified vendors. A third entry on the same contract portal also references the M67, M111, and M112 under the W519TC25R0038 solicitation, further confirming the program’s active status across several procurement actions.
The pairing of the M111 with the M112 Practice Body is itself revealing. Training variants typically enter procurement alongside their lethal counterparts only after the weapon design has been finalized and approved for fielding. The Army would not invest in a dedicated practice version of a grenade still stuck in early testing. This sequencing strongly suggests the M111 has passed qualification testing, even though the solicitations themselves do not spell out test results or approval dates in the publicly available summaries.
The continued presence of the M67 in these same solicitations also matters. Rather than replacing the fragmentation grenade outright, the Army appears to be adding the M111 as a complementary tool. Offensive grenades differ from fragmentation types in a critical way: they rely primarily on blast overpressure rather than metal fragments to neutralize threats. That design philosophy allows soldiers to use them at closer range, including inside buildings, without the same risk of shrapnel injuring the thrower or nearby friendly forces. For urban operations, where rooms and hallways compress engagement distances to just a few meters, this distinction can be the difference between a viable tactic and an unacceptable friendly-fire risk.
Operationally, that means commanders could tailor grenade loads more precisely to the mission. A patrol preparing to clear dense urban terrain might prioritize offensive grenades for room entry and hallway engagements, while still carrying M67s for outdoor use against entrenched positions. The coexistence of both types in the supply chain suggests the Army is moving toward a more nuanced toolkit rather than a one-size-fits-all approach.
What remains uncertain
Several key details are absent from the available procurement records. The solicitations do not specify the exact date the Army formally cleared the M111 for service. Some defense media outlets have referenced a 2024 approval, but the primary government documents accessible through sam.gov do not include a signed clearance memo or a formal milestone decision record in their public-facing summaries. The latest publicly available updates come from these listings, and they confirm active procurement activity without pinpointing the precise moment of official adoption.
Production costs remain equally opaque. Commentary in trade publications has speculated on per-unit pricing and potential savings from shared components with existing grenades, but no verified figure appears in the government solicitations. The “Sources Sought” classification suggests the Army is still gathering cost and capability data from potential manufacturers, which means final contract values and unit prices have not been locked in. Until a firm-fixed-price or similar contract award is posted, any specific dollar figures should be treated as unconfirmed.
The M111’s exact technical specifications, including blast radius, fuse delay, weight, and explosive fill, are not detailed in the publicly available portions of these solicitations. Military procurement documents often restrict such information to registered vendors or classified annexes, especially when it bears directly on lethality and survivability metrics. Without those specs, independent assessment of how the M111 compares to allied offensive grenades or to the M67’s known performance envelope is not possible from open sources alone.
There is also no public information about which companies have responded to the solicitations or which facilities might produce the M111. The defense industrial base for hand grenades has historically been narrow, with a small number of Army-owned or contractor-operated ammunition plants handling production. Whether the Army intends to use existing facilities, shift work between plants, or stand up new production lines is an open question with direct implications for how quickly units in the field will actually receive the new grenade.
Another unknown is how the M111 will be prioritized relative to other modernization efforts competing for the same budget lines. Hand grenades are inexpensive compared to vehicles or missiles, but they still draw from finite ammunition procurement accounts. If higher-cost programs encounter overruns, funding profiles for lower-visibility items like grenades can slip, delaying large-scale fielding even after a design is technically approved.
How to read the evidence
The sam.gov solicitations are primary-source government documents, and they carry the highest evidentiary weight in this story. They confirm three things beyond reasonable dispute: the M111 exists as a designated Army munition, the service is actively seeking manufacturers for it, and the program is mature enough to include a dedicated training variant. Everything else in the public discussion, from approval timelines to cost estimates to performance claims, rests on secondary reporting that cannot be independently verified against these records.
This distinction matters because defense procurement stories often outrun the available evidence. A “Sources Sought” notice is a real and meaningful step, but it is not the same as a production contract award. The Army has confirmed its intent to buy the M111, yet the gap between intent and delivery can stretch for years in military acquisition. Readers following this story should watch for two specific future milestones: a formal Request for Proposals, which would signal the competitive bidding phase has begun, and a contract award notice, which would confirm a manufacturer, a delivery schedule, and a price.
The broader context is worth examining with clear eyes as well. Much of the commentary around the M111 frames it as a response to lessons learned in recent urban conflicts, from Mosul to Mariupol. That framing is plausible given the grenade’s offensive role, but it is not directly supported by the procurement documents themselves, which do not attribute the program to any particular campaign, after-action report, or operational shortfall. Without explicit justification language in the public record, linking the M111 to specific battles remains an informed hypothesis rather than a documented fact.
What the evidence does support is a more modest but still significant conclusion: after more than half a century of relying on a single standard hand grenade, the U.S. Army is diversifying its inventory. The emergence of the M111 offensive grenade, paired with a purpose-built practice body and pursued through multiple solicitations, indicates a deliberate effort to give small units additional options for close combat. How quickly that intent translates into grenades in rucksacks will depend on industrial capacity, budget stability, and the outcome of contract competitions that have yet to be publicly decided.
Until those next steps appear in the federal record, the M111 should be understood as a confirmed program in transition: past design and testing, moving into the manufacturing phase, but not yet a ubiquitous item of issue. For soldiers, planners, and observers alike, the key is to separate what the documents show from what they merely imply, and to recognize that in defense acquisition, even seemingly simple weapons can follow long, complex paths from concept to combat.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
